Literature DB >> 3143760

Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.

M M Hogan1, S N Vogel.   

Abstract

Previous studies have shown that the activation of murine macrophages to a fully tumoricidal state requires that specific environmental signals be delivered to the macrophage in a step-wise manner: a "priming" signal first renders the macrophage stimulated, but not cytolytic. The addition of a second or "trigger" signal to the primed macrophage results in tumoricidal activity. One potent priming signal has been identified as IFN-gamma and one often used trigger signal for endotoxin-responsive (Lpsn) macrophages is LPS. In contrast to LPS-responsive macrophage, rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages fail to become cytolytic in response to protein-free, phenol-water-extracted LPS preparations, but become tumoricidal when exposed in vitro to protein-rich butanol-extracted LPS or purified lipid A-associated proteins. Further characterization of the activation requirements of the C3H/HeJ macrophages revealed that for optimal elaboration of TNF in vitro, two signals were also required: rIFN-gamma and a second signal that contained LAP. C3H/HeJ macrophages macrophages primed with rIFN-gamma failed to produce TNF in response to any concentration of protein-free phenol-water extracted LPS, even when supernatants were concentrated before assaying for functional activity in a standard TNF L929 fibroblast assay. Although exposure of rIFN-gamma-primed C3H/HeJ macrophages to LAP resulted in a fully tumoricidal state equivalent to that exhibited by C3H/OuJ macrophages, the levels of TNF produced remained discrepant. Under identical conditions, C3H/OuJ macrophages produced approximately fivefold more TNF (11,776 U/ml) than C3H/HeJ macrophages (2,399 U/ml). This suggests that although C3H/HeJ macrophages can respond functionally in a "normal" manner given the correct signals, they remain quantitatively deficient in the production of certain proteins. In this system, the elaboration of TNF and macrophage-mediated tumor cell lysis were shown to be dissociable events. The tumor target used in these studies (P815) was shown to be resistant to as much as 40,000 U/ml of purified rTNF. In addition, C3H/OuJ macrophage cultures exposed to LPS only (which resulted in the production of high levels of TNF), failed to lyse these targets. Lastly, anti-mouse TNF antibody added to macrophage cultures had no effect on the induction of tumor cell lysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143760

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance.

Authors:  B E Henricson; W R Benjamin; S N Vogel
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

Review 2.  Pathogenic mechanisms of neuronal damage in the AIDS dementia complex.

Authors:  S Swingler
Journal:  Mol Pathol       Date:  1997-04

3.  Paclitaxel (Taxol)-induced killing of Leishmania major in murine macrophages.

Authors:  T M Doherty; A Sher; S N Vogel
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

4.  Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages.

Authors:  K A Kelly; M R Hill; K Youkhana; F Wanker; J M Gimble
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

6.  Endotoxin administration to humans primes alveolar macrophages for increased production of inflammatory mediators.

Authors:  P D Smith; A F Suffredini; J B Allen; L M Wahl; J E Parrillo; S M Wahl
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

7.  Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii.

Authors:  S A Theus; M J Linke; R P Andrews; P D Walzer
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin.

Authors:  H A Gelbard; H S Nottet; S Swindells; M Jett; K A Dzenko; P Genis; R White; L Wang; Y B Choi; D Zhang
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Murine macrophage activation by staphylococcal exotoxins.

Authors:  S D Fleming; J J Iandolo; S K Chapes
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

10.  Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages.

Authors:  P D Smith; S S Saini; M Raffeld; J F Manischewitz; S M Wahl
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.